Live Cell Imaging Market by Product (Consumables, Instruments, Services, and Software), by Application (Stem Cells, Cell Biology, and Drug Discovery), by Technology (Fluorescence Recovery After Photo Bleaching, Time Lapse Microscopy, High Content Screening, Fluorescence Resonance Energy Transfer, and Others), and by End-User (Biotechnology and Pharmaceutical Companies, Research Institutes, and Contract Research Organizations)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020–2029

                                          
Abstract
                    
The report covers a forecast and an analysis of the live cell imaging market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes the drivers and restraints of the live cell imaging market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the live cell imaging market on a global as well as regional level.

In order to give the users of this report a comprehensive view of the live cell imaging market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.


The report provides company market share analysis to give a broader overview of the key players in the live cell imaging market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research& development, and regional expansion of major participants involved in the market on a global and regional basis.

The study provides a decisive view of the live cell imaging market by segmenting it based on the product, technology, application, end-user, and region. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Some key players of the global live cell imaging market include Danaher Corporation, Nikon Corporation, Olympus Corporation, GE Healthcare, Bruker Corporation, Thermo Fischer Scientific, Sartorius, Etaluma, BioTek instruments, Perkin Elmer, Carl Zeiss, cytoSMART Technologies, and NanoEnTek.

This report segments the global live cell imaging market as follows:

Global Live Cell imaging Market: By Product

	Instruments
	Consumables
	Software
	services

Global Live Cell imaging Market: By Technology

	Time Lapse Microscopy
	Fluorescence Recovery After Photo Bleaching (FRAP)
	High Content Screening (HCS)
	Fluorescence Resonance Energy Transfer (FRET)
	Others

Global Live Cell imaging Market: By Application

	Cell Biology
	Stem Cells
	Drug Discovery

Global Live Cell imaging Market: By End-User

	Pharmaceutical and Biotechnology Companies
	Research Institutes
	Contract Research Organizations

Global Live Cell imaging Market: By Region

	North America
	
		U.S.
	
	
	Europe
	
		UK
		France
		Germany
	
	
	Asia Pacific
	
		China
		Japan
		India
	
	
	Latin America
	
		Brazil
	
	
	Middle East and Africa